TR200102612T2 - Mide asidi salgılanmasını önleyen imidazo piridin türevleri. - Google Patents

Mide asidi salgılanmasını önleyen imidazo piridin türevleri.

Info

Publication number
TR200102612T2
TR200102612T2 TR2001/02612T TR200102612T TR200102612T2 TR 200102612 T2 TR200102612 T2 TR 200102612T2 TR 2001/02612 T TR2001/02612 T TR 2001/02612T TR 200102612 T TR200102612 T TR 200102612T TR 200102612 T2 TR200102612 T2 TR 200102612T2
Authority
TR
Turkey
Prior art keywords
prevent
secretion
imidazo pyridine
pyridine derivatives
stomach acid
Prior art date
Application number
TR2001/02612T
Other languages
English (en)
Inventor
Amin Kosrat
Dahlstr�m Mikael
Nordberg Peter
Starke Ingemar
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200102612T2 publication Critical patent/TR200102612T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Mevcut bulus, fenil kisminin ve imidazo piridinin kisminin 6 pozisyonundaki karboksamid grubu ile yer degistirdigi ve ekzojen ya da endojen olarak uyarilmis olan mide asidi salgilanmasini engelleyen ve dolayisiyla iltihapli gastrointestinal hastaliklarin önlenmesinde ve tedavisinde kullanilabilen, formül (I)'in imidazo piridin türevleri ile ilgilidir.
TR2001/02612T 1998-04-29 1999-04-23 Mide asidi salgılanmasını önleyen imidazo piridin türevleri. TR200102612T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds

Publications (1)

Publication Number Publication Date
TR200102612T2 true TR200102612T2 (tr) 2002-06-21

Family

ID=20411154

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2000/03149T TR200003149T2 (tr) 1998-04-29 1999-04-23 Mide asidi salgılanmasını önleyen imidazo piridin türevleri.
TR2001/02612T TR200102612T2 (tr) 1998-04-29 1999-04-23 Mide asidi salgılanmasını önleyen imidazo piridin türevleri.
TR2001/02728T TR200102728T2 (tr) 1998-04-29 1999-04-23 Mide asit salgısını inhibe eden imidazo piridin türevleri
TR2000/03176T TR200003176T2 (tr) 1998-04-29 1999-04-23 Mide asit salgısını inhibe eden imidazo piridin türevleri

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2000/03149T TR200003149T2 (tr) 1998-04-29 1999-04-23 Mide asidi salgılanmasını önleyen imidazo piridin türevleri.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2001/02728T TR200102728T2 (tr) 1998-04-29 1999-04-23 Mide asit salgısını inhibe eden imidazo piridin türevleri
TR2000/03176T TR200003176T2 (tr) 1998-04-29 1999-04-23 Mide asit salgısını inhibe eden imidazo piridin türevleri

Country Status (34)

Country Link
US (2) US6313137B1 (tr)
EP (4) EP1073657B1 (tr)
JP (2) JP3692034B2 (tr)
KR (3) KR100595806B1 (tr)
CN (2) CN1165535C (tr)
AR (2) AR015768A1 (tr)
AT (4) ATE312101T1 (tr)
AU (2) AU769190B2 (tr)
BR (2) BR9909995B1 (tr)
CA (2) CA2329921A1 (tr)
CZ (2) CZ292567B6 (tr)
DE (4) DE69937077T2 (tr)
DK (2) DK1073657T3 (tr)
EE (2) EE04676B1 (tr)
ES (2) ES2252975T3 (tr)
HK (5) HK1033457A1 (tr)
HU (2) HUP0102425A3 (tr)
ID (2) ID27530A (tr)
IL (4) IL139200A0 (tr)
IS (2) IS5684A (tr)
MY (2) MY121389A (tr)
NO (2) NO317262B1 (tr)
NZ (2) NZ507639A (tr)
PL (2) PL195000B1 (tr)
RU (2) RU2238271C2 (tr)
SA (2) SA99200065B1 (tr)
SE (1) SE9801526D0 (tr)
SI (1) SI1073656T1 (tr)
SK (2) SK14912000A3 (tr)
TR (4) TR200003149T2 (tr)
TW (2) TWI250159B (tr)
UA (2) UA66846C2 (tr)
WO (2) WO1999055705A1 (tr)
ZA (2) ZA200005796B (tr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
ATE324871T1 (de) * 2001-02-13 2006-06-15 Astrazeneca Ab Neue formulierung mit modifizierter freisetzung
EE05234B1 (et) * 2001-03-08 2009-12-15 Astrazeneca Ab 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
KR20050052500A (ko) 2002-09-19 2005-06-02 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 이미다조피리딘
KR20050086584A (ko) 2002-11-19 2005-08-30 알타나 파마 아게 8-치환 이미다조피리딘
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
BRPI0406427B8 (pt) 2003-03-10 2021-05-25 Astrazeneca Ab processo para a preparação de roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1682133A1 (en) * 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EA011512B1 (ru) * 2004-12-17 2009-04-28 Ракуалиа Фарма Инк. Производные хромана, полезные в качестве антагонистов кислотной помпы
DK1861074T3 (da) 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
JP5206405B2 (ja) * 2005-03-21 2013-06-12 エムイーアイ・ファーマ・インコーポレイテッド イミダゾ［１，２−ａ］ピリジン誘導体：製造および医薬用途
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
WO2006100119A1 (en) * 2005-03-24 2006-09-28 Glaxo Group Limited Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
RU2384331C2 (ru) * 2005-12-05 2010-03-20 Пфайзер Продактс Инк. Способ лечения аномального роста клеток
EP1963302B1 (en) * 2005-12-05 2013-02-27 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
WO2007107827A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
US8728527B2 (en) 2006-07-24 2014-05-20 Luminus Biosciences, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
CN102066396B (zh) * 2008-03-31 2014-03-12 科学与工业研究委员会 用作抗胃液分泌或抗溃疡剂的药物组合物
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
EP2452680B1 (en) * 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
CN105358151B (zh) * 2013-06-25 2019-04-12 豪夫迈·罗氏有限公司 用于治疗脊髓性肌萎缩的化合物
BR112016013734A2 (pt) 2013-12-16 2017-08-08 Asana Biosciences Llc Composto, composição farmacêutica, kit, e uso de um composto
MX367267B (es) * 2014-03-24 2019-08-12 Arqule Inc Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. CHROMATOGRAPHIC RESIN WITH A LIGAND WITH ANION EXCHANGE-HYDROPHOBIC MIXED MODE
EP3774719A1 (de) 2018-04-10 2021-02-17 Bayer Aktiengesellschaft Verfahren zur herstellung von 2,6-dialkylphenyl-essigsäuren
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
ES2949232T3 (es) 2019-11-04 2023-09-26 Cinclus Pharma Holding Ab Publ Formulación Oral de X842
CA3235361A1 (en) 2021-11-05 2023-05-11 Kjell JARRING Polymorphs of the hydrochloride salt of linaprazan glurate
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
SK14912000A3 (sk) 2001-06-11
NO20005451D0 (no) 2000-10-27
TR200003149T2 (tr) 2001-03-21
CZ293977B6 (cs) 2004-09-15
DK1073656T3 (da) 2006-01-16
TWI250159B (en) 2006-03-01
KR20010043134A (ko) 2001-05-25
NZ507639A (en) 2004-01-30
CZ20003982A3 (cs) 2001-02-14
EP1073657A1 (en) 2001-02-07
EP1073656A1 (en) 2001-02-07
CA2329921A1 (en) 1999-11-04
HK1071139A1 (en) 2005-07-08
JP2002513024A (ja) 2002-05-08
ID26819A (id) 2001-02-15
IL139200A (en) 2010-04-29
CN1174980C (zh) 2004-11-10
US6313136B1 (en) 2001-11-06
EP1491543A1 (en) 2004-12-29
CN1307577A (zh) 2001-08-08
CN1306533A (zh) 2001-08-01
EP1073657B1 (en) 2005-12-07
NO20005450D0 (no) 2000-10-27
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
DE69927803T2 (de) 2006-07-06
KR20050121760A (ko) 2005-12-27
NO317262B1 (no) 2004-09-27
AU769108B2 (en) 2004-01-15
NO20005451L (no) 2000-12-27
PL343801A1 (en) 2001-09-10
AU769190B2 (en) 2004-01-22
ID27530A (id) 2001-04-12
ZA200005797B (en) 2002-01-18
RU2235725C2 (ru) 2004-09-10
DE69937077D1 (de) 2007-10-18
MY121389A (en) 2006-01-28
IL139297A (en) 2007-06-03
SA99200064B1 (ar) 2006-10-11
ATE372339T1 (de) 2007-09-15
ATE372340T1 (de) 2007-09-15
AU4300699A (en) 1999-11-16
EP1491543B1 (en) 2007-09-05
DE69928792D1 (de) 2006-01-12
TR200003176T2 (tr) 2001-03-21
PL195000B1 (pl) 2007-07-31
BR9909995A (pt) 2000-12-26
CA2329922C (en) 2006-04-11
CZ20003981A3 (cs) 2001-03-14
PL343797A1 (en) 2001-09-10
DE69937076T2 (de) 2008-05-29
EP1491542A3 (en) 2005-01-05
EP1073656B1 (en) 2005-10-19
SK14922000A3 (sk) 2001-06-11
NZ507638A (en) 2003-10-31
SA99200065A (ar) 2005-12-03
SA99200065B1 (ar) 2006-11-07
ES2249913T3 (es) 2006-04-01
JP2002513025A (ja) 2002-05-08
KR20010043133A (ko) 2001-05-25
KR100595806B1 (ko) 2006-07-03
HUP0102425A3 (en) 2002-12-28
HK1036981A1 (en) 2002-01-25
IL139297A0 (en) 2001-11-25
KR100595805B1 (ko) 2006-07-03
HK1033457A1 (en) 2001-08-31
DK1073657T3 (da) 2006-03-13
HUP0102425A2 (hu) 2001-11-28
IS5684A (is) 2000-10-25
TW490466B (en) 2002-06-11
CZ292567B6 (cs) 2003-10-15
HK1036984A1 (en) 2002-01-25
CA2329922A1 (en) 1999-11-04
BR9909996B1 (pt) 2010-08-24
JP3883383B2 (ja) 2007-02-21
AR015769A1 (es) 2001-05-16
EP1491542A2 (en) 2004-12-29
KR100650472B1 (ko) 2006-11-28
WO1999055705A1 (en) 1999-11-04
HUP0102313A3 (en) 2002-10-28
SK285768B6 (sk) 2007-07-06
UA66846C2 (uk) 2004-06-15
SE9801526D0 (sv) 1998-04-29
AR015768A1 (es) 2001-05-16
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
HUP0102313A2 (hu) 2001-12-28
ES2252975T3 (es) 2006-05-16
NO20005450L (no) 2000-12-22
DE69937077T2 (de) 2008-05-29
ATE312101T1 (de) 2005-12-15
BR9909995B1 (pt) 2010-07-13
US6313137B1 (en) 2001-11-06
RU2238271C2 (ru) 2004-10-20
IL139200A0 (en) 2001-11-25
IS5683A (is) 2000-10-25
JP3692034B2 (ja) 2005-09-07
EE04916B1 (et) 2007-10-15
DE69937076D1 (de) 2007-10-18
BR9909996A (pt) 2000-12-26
ZA200005796B (en) 2002-01-18
DE69927803D1 (de) 2006-03-02
WO1999055706A9 (en) 2000-03-16
AU4300799A (en) 1999-11-16
HK1033317A1 (en) 2001-08-24
MY121379A (en) 2006-01-28
ATE307130T1 (de) 2005-11-15
EE04676B1 (et) 2006-08-15
DE69928792T2 (de) 2006-07-20
NO318203B1 (no) 2005-02-14
EE200000626A (et) 2002-04-15
TR200102728T2 (tr) 2002-06-21
CN1165535C (zh) 2004-09-08
UA67769C2 (uk) 2004-07-15

Similar Documents

Publication Publication Date Title
TR200102612T2 (tr) Mide asidi salgılanmasını önleyen imidazo piridin türevleri.
TR199902060T2 (tr) Gastrik asit salgilanmasinin inhibisyonu için bilesikler.
SE9704404D0 (sv) New compounds
DE60036726D1 (de) Harnstoff derivate als entzündungshemmende mittel
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
YU21401A (sh) Tetrahidropiridoetri
ATE224386T1 (de) Neue in 6-position substituierte phenanthridine
TR199802554T2 (tr) Yeni bilesikler
IL145565A0 (en) Pyridine-2,3-dicarboxylic acid diamides
TR199802060T2 (tr) Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi.
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
SE9802794D0 (sv) New compounds
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE0102808D0 (sv) New compounds
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
TR200102481T2 (tr) Fazlı zincir muadili içeren 2-aminopiridinler.
NO20060425L (no) Ny imidazopyridinforbindelse II med terapeutisk effekt
ES2150494T3 (es) Derivados sustituidos de quinolina y su utilizacion como inhibidores de la secrecion de acido gastrico.
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
RU94015603A (ru) Производные 3-гидроксиантраниловой кислоты, способ их получения, фармацевтическая композиция, способ лечения и промежуточные соединения